News | 05 August 2021
Alembic gets USFDA nod for Clomipramine Hydrochloride
It had an estimated market size of US $ 32 million as of June 2021
It had an estimated market size of US $ 32 million as of June 2021
EPS climbs to Rs 9.25 for the quarter
It is part of the company’s pain/analgesics portfolio of OTC products
Arrow is the marketing partner in US
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Robust demand for the product across the Middle East, Africa and Latin America
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
India business is growing as per projections; whereas US business will bounce back soon.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Turnover of API division of ISLL stood at Rs 856.58 crore
It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.
The company posted net profit of Rs.2.43 crores for the period ended June 30, 2020.
The group now has 320 approvals and has so far filed over 400 ANDAs
It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
